Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression.
dc.contributor.affiliation | Department of Infectious Disease, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA. | |
dc.contributor.affiliation | University of California San Francisco, San Francisco, California, USA. | |
dc.contributor.affiliation | San Francisco General Hospital and Trauma Center, San Francisco, California, USA. | |
dc.contributor.affiliation | Zambia Ministry of Health, Lusaka, Zambia. | |
dc.contributor.affiliation | Division of Global HIV & Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia. | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia, Lusaka, Zambia jmpry@ucdavis.edu. | |
dc.contributor.affiliation | Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. | |
dc.contributor.affiliation | Department of Public Health Environments and Society, London School of Hygiene & Tropical Medicine, London, UK. | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. | |
dc.contributor.affiliation | Department of Internal Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA. | |
dc.contributor.affiliation | CIDRZ | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ) | |
dc.contributor.author | Pry JM | |
dc.contributor.author | Sikombe K | |
dc.contributor.author | Mody A | |
dc.contributor.author | Iyer S | |
dc.contributor.author | Mutale J | |
dc.contributor.author | Vlahakis N | |
dc.contributor.author | Savory T | |
dc.contributor.author | Wa Mwanza M | |
dc.contributor.author | Mweebo K | |
dc.contributor.author | Mwila A | |
dc.contributor.author | Mwale C | |
dc.contributor.author | Mukumbwa-Mwenechanya M | |
dc.contributor.author | Kerkhoff AD | |
dc.contributor.author | Sikazwe I | |
dc.contributor.author | Bolton Moore C | |
dc.contributor.author | Mwamba D | |
dc.contributor.author | Geng EH | |
dc.contributor.author | Herce ME | |
dc.date.accessioned | 2025-05-23T11:40:51Z | |
dc.date.issued | 2022-Jan | |
dc.description.abstract | INTRODUCTION: The Zambian Ministry of Health (MoH) issued COVID-19 mitigation guidance for HIV care immediately after the first COVID-19 case was confirmed in Zambia on 18 March 2020. The Centre for Infectious Disease Research in Zambia implemented MoH guidance by: 1) extending antiretroviral therapy (ART) refill duration to 6 multi-month dispensation (6MMD) and 2) task-shifting communication and mobilisation of those in HIV care to collect their next ART refill early. We assessed the impact of COVID-19 mitigation guidance on HIV care 3 months before and after guidance implementation. METHODS: We reviewed all ART pharmacy visit data in the national HIV medical record for PLHIV in care having ≥1 visit between 1 January-30 June 2020 at 59 HIV care facilities in Lusaka Province, Zambia. We undertook a before-after evaluation using mixed-effects Poisson regression to examine predictors and marginal probability of early clinic return (pharmacy visit >7 days before next appointment), proportion of late visit (>7 days late for next appointment) and probability of receiving a 6MMD ART refill. RESULTS: A total of 101 371 individuals (64% female, median age 39) with 130 486 pharmacy visits were included in the analysis. We observed a significant increase in the adjusted prevalence ratio (4.63; 95% CI 4.45 to 4.82) of early return before compared with after guidance implementation. Receipt of 6MMD increased from a weekly mean of 47.9% (95% CI 46.6% to 49.2%) before to 73.4% (95% CI 72.0% to 74.9%) after guidance implementation. The proportion of late visits (8-89 days late) was significantly higher before (18.8%, 95% CI17.2%to20.2%) compared with after (15.1%, 95% CI13.8%to16.4%) guidance implementation . CONCLUSIONS: Timely issuance and implementation of COVID-19 mitigation guidance involving task-shifted patient communication and mobilisation alongside 6MMD significantly increased early return to ART clinic, potentially reducing interruptions in HIV care during a global public health emergency. | |
dc.identifier.doi | 10.1136/bmjgh-2021-007312 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10321 | |
dc.source | BMJ global health | |
dc.title | Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression. |
Files
Original bundle
1 - 1 of 1